Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Efarmogi AB
AB
Active
Org 5592688989
Sandgärdsgatan 16, 352 30
Växjö
Restaurant activities
·
NACE 5611
Est. 2020 · 5 years old
20-49 employees
Monitor
Share
Sweden
/
Companies
/
Restaurant activities
/
Efarmogi AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
7M
6M
4M
2M
0M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 1M
1M
2024
2025: 6M (+500% vs 2024)
6M
+500%
2025
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
5 860
1 133
0
0
0
Staff expenses
−2 169
−537
—
—
—
EBITDA
359
−94
0
0
0
Depreciation & amort.
−14
−1
−0
−0
−0
EBIT
345
−95
0
0
0
Net financials
−45
−2
—
—
—
Profit before tax
301
−97
0
0
0
Tax
−48
—
−0
−0
−0
Net profit
253
−97
0
0
0
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
1 993
640
25
25
25
Equity
182
−72
25
25
25
Long-term debt
—
—
0
0
0
Short-term debt
1 812
711
0
0
0
Total debt
1 812
711
—
—
—
Financial ratios
5-year trend
EBITDA margin
6,1 %
This company
15,8 %
Market median
This company
Market median
61% below market
2021
2025
Equity ratio
9,1 %
This company
38,2 %
Market median
This company
Market median
76% below market
2021
2025
Return on equity
139,4 %
This company
18,4 %
Market median
This company
Market median
658% above market
2021
2025
Net profit margin
4,3 %
This company
8,1 %
Market median
This company
Market median
47% below market
2021
2025
Asset turnover
2,94×
This company
1,12×
Market median
This company
Market median
162% above market
2021
2025
Debt / equity
9,98×
This company
0,62×
Market median
This company
Market median
>999% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-04-01 – 2023-03-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-04-01 – 2022-03-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-08-01 – 2021-03-31
View
PDF
More on Efarmogi AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
